Expression and regulation of hepatic drug and bile acid transporters

Toxicology

Volumn 153, Issue 1-3, 2000, Pages 203-219

  Lecureur, Valérie ^a   Courtois, Arnaud ^a   Payen, Léa ^a   Verhnet, Laurent ^a   Guillouzo, André ^a   Fardel, Olivier ^a  

^a UNIVERSITÉ DE RENNES 1   (France)

Author keywords

Bile duct ligation; Bile salt export pump; Multidrug resistance

Indexed keywords

BILE SALT; GLYCOPROTEIN P;

ARTICLE; BILIARY EXCRETION; CHOLESTASIS; DISEASE ASSOCIATION; GENE EXPRESSION REGULATION; HUMAN; ION TRANSPORT; LIVER CLEARANCE; LIVER DISEASE; NONHUMAN; ONTOGENY; PRIORITY JOURNAL;

ANIMALS; BILE ACIDS AND SALTS; CARRIER PROTEINS; HUMANS; HYDROXYSTEROID DEHYDROGENASES; LIVER; LIVER NEOPLASMS; MEMBRANE GLYCOPROTEINS;

EID: 0034676510     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-483X(00)00315-2     Document Type: Article

References (129)

1. Molecular characterization and tissue distribution of a new organic anion transporter subtype (oatp3) that transports thyroid hormones and taurocholate and comparison with oatp2
2. The multidrug resistance (mdr1) gene product functions as an ATP channel
3. Characterization of cloned rat liver Na(+)-bile acid cotransporter using peptide and fusion protein antibodies
4. The gene encoding multidrug resistance is induced and expressed at high levels during pregnancy in the secretory epithelium of the uterus
5. What have we learnt thus far from mice with disrupted P-glycoprotein genes?
6. Phylogenic and ontogenic expression of hepatocellular bile acid transport
7. cDNA cloning of the hepatocyte canalicular isoform of the multidrug resistance protein, cMRP, reveals a novel conjugate export pump deficient in hyperbilirubinemic mutant rats
8. A gene encoding a P-type ATPase mutated in two forms of hereditary cholestasis
9. Coinduction of MDR-1 multidrug-resistance and cytochrome P-450 genes in rat liver by xenobiotics
10. Fibrates induce mdr2 gene expression and biliary phospholipid secretion in the mouse
11. Identification of a sister gene to P-glycoprotein
12. Taxol resistance mediated by transfection of the liver-specific sister gene of P-glycoprotein
13. Regulation of mdr RNA levels in response to cytotoxic drugs in rodent cells
14. Multiplicity of biliary excretion mechanisms for irinotecan, CPT-11, and its metabolites in rats
15. Inhibition of multidrug resistance-associated protein (MRP) activity by rifampicin in human multidrug-resistant lung tumor cells
16. Up-regulation of multidrug resistance-associated protein 2 (MRP2) expression in rat hepatocytes by dexamethasone
17. Differential regulation of canalicular multispecific organic anion transporter (cMOAT) expression by the chemopreventive agent oltipraz in primary rat hepatocytes and in rat liver
18. Drug resistance and ATP-dependent conjugate transport mediated by the apical multidrug resistance protein, MRP2, permanently expressed in human and canine cells
19. Mutations in the MDR3 gene cause progressive familial intrahepatic cholestasis
20. Defect of multidrug-resistance 3 gene expression in a subtype of progressive familial intrahepatic cholestasis
21. Dexamethasone modulation of multidrug transporters in normal tissues
22. Cisplatin induces renal expression of P-glycoprotein and canalicular multispecific organic anion transporter
23. Ontogenic expression of the Na(+)-independent organic anion transporting polypeptide (oatp) in rat liver and kidney
24. Carcinogen-induced mdr overexpression is associated with xenobiotic resistance in rat preneoplastic liver nodules and hepatocellular carcinomas
25. Modulation of multidrug resistance gene expression in rat hepatocytes maintained under various culture conditions
26. Overexpression of the multidrug resistance gene product in adult rat hepatocytes during primary culture
27. P-glycoprotein expression in human, mouse, hamster and rat hepatocytes in primary culture
28. Regulation by dexamethasone of P-glycoprotein expression in cultured rat hepatocytes
29. Constitutive expression of functional P-glycoprotein in rat hepatoma cells
30. Rifampicin enhances anti-cancer drug accumulation and activity in multidrug-resistant cells
31. P-glycoprotein induction in rat liver epithelial cells in response to acute 3-methylcholanthrene treatment
32. Up-regulation of P-glycoprotein expression in rat liver cells by acute doxorubicin treatment
33. Induction of multidrug resistance gene expression in rat liver cells in response to acute treatment by the DNA-damaging agent methyl methanesulfonate
34. Prolactin increases hepatic Na+/taurocholate co-transport activity and messenger RNA post partum
35. Regulation of the rat liver sodium-dependent bile acid cotransporter gene by prolactin. Mediation of transcriptional activation by Stat5
36. Molecular regulation of sinusoidal liver bile acid transporters during cholestasis
37. The sister of P-glycoprotein represents the canalicular bile salt export pump of mammalian liver
38. Differential expression of basolateral and canalicular organic anion transporters during regeneration of rat liver
39. Expression of a multidrug resistance gene in human cancers
40. Cloning and characterization of two human polyspecific organic cation transporters
41. Genetic analysis of the multidrug transporter
42. Genetic mapping of Na+-taurocholate cotransporting polypeptide to mouse chromosome 12
43. Drug excretion mediated by a new prototype of polyspecific transporter
44. Functional expression cloning and characterization of the hepatocyte Na+/bile acid cotransport system
45. Molecular cloning, chromosomal localization, and functional characterization of a human liver Na+/bile acid cotransporter
46. Differential ontogenic regulation of basolateral and canalicular bile acid transport proteins I rat liver
47. Structural, mechanistic and clinical aspects of MRP1
48. Hepatic expression of multidrug resistance-associated protein-like proteins maintained in eisai hyperbilirubinemic rats
49. Antifolate resistance mediated by the multidrug resistance proteins MRP1 and MRP2
50. Overexpression of the MDR1 gene and P-glycoprotein in human hepatocellular carcinoma
51. Expression cloning of a rat liver Na(+)-independent organic anion transporter
52. Genetic basis of progressive familial intrahepatic cholestasis
53. Estradiol induction of rhodamine 123 efflux and the multidrug resistance pump in rat pituitary tumor cells
54. Hepatocanalicular bile salt export pump deficiency in patients with progressive familial intrahepatic cholestasis
55. Differential expression of multidrug resistance (mdr) and canalicular multispecific organic anion transporter (cMOAT) genes following extrahepatic biliary obstruction in rats
56. Immunohistochemical distribution and functional characterization of an organic anion transporting polypeptide 2 (oatp2)
57. Sequence analysis and functional characterization of the 5'-flanking region of the rat multidrug resistance protein 2 (mrp2) gene
58. Induction of cMrp/cMoat gene expression by cisplatin, 2-acetylaminofluorene, or cycloheximide in rat hepatocytes
59. Induction of hepatic mrp2 (cmrp/cmoat) gene expression in nonhuman primates treated with rifampicin or tamoxifen
60. Cloning and functional characterization of a potential-sensitive, polyspecific organic cation transporter (OCT3) most abundantly expressed in placenta
61. Modulation by drugs of human hepatic sodium-dependent bile acid transporter (sodium taurocholate cotransporting polypeptide) activity
62. cDNA cloning and inducible expression of human multidrug resistance associated protein 3 (MRP3)
63. A canalicular multispecific organic anion transporter (cMOAT) antisense cDNA enhances drug sensitivity in human hepatic cancer cells
64. Analysis of expression of cMOAT (MRP2), MRP3, MRP4, and MRP5, homologues of the multidrug resistance-associated protein gene (MRP1), in human cancer cell lines
65. Expression of human MRP6, a homologue of the multidrug resistance protein gene MRP1, in tissues and cancer cells
66. MRP3, an organic anion transporter able to transport anti-cancer drugs
67. Molecular mechanisms of cholestasis: Causes and consequences of impaired bile formation
68. Expression pattern of MRP in human tissues and adult solid tumor cell lines
69. Regulation of the multidrug resistance protein 2 in the rat liver by lipopolysaccharide and dexamethasone
70. Dexamethasone- and osmolarity-dependent expression of the multidrug- resistance protein 2 in cultured rat hepatocytes
71. Molecular and functional characterization of an organic anion transporting polypeptide cloned from human liver
72. Assignment of the human organic anion transporting polypeptide (OATP) gene to chromosome 12p12 by fluorescence in situ hybridization
73. Genetic mapping of hepatocanalicular transporters establishes sister-P-glycoprotein (spgp) as a candidate for the major gallstone gene (Lith1)
74. The antiprogestatin drug RU 486 potentiates doxorubicin cytotoxicity in multidrug resistant cells through inhibition of P-glycoprotein function
75. Differential regulation of mdr genes in response to 2-acetylaminofluorene treatment in cultured rat and human hepatocytes
76. Differential expression of the polyspecific drug transporter OCT1 in rat hepatocarcinoma cells
77. Cloning and expression of murine sister of P-glycoprotein reveals a more discriminating transporter than MDR1/P-glycoprotein
78. Expression of the bile salt export pump is maintained after chronic cholestasis in the rat
79. Characterization of vincristine transport by the Mr 190,111 multidrug resistance protein (MRP): Evidence for cotransport with reduced glutathione
80. Regulation of renal oatp mRNA expression by testosterone
81. MDR1/P-GP expression as a prognostic factor in acute leukemias
82. Regulation of the multidrug resistance gene in regenerating rat liver
83. Postnatal development of organic cation transport in the rat liver
84. Methotrexate is excreted into the bile by canalicular multispecific organic anion transporter in rats
85. Substrate specificity of sinusoidal bile acid and organic anion uptake systems in rat and human liver
86. Molecular aspects of hepatobiliary transport
87. Expression of multidrug resistance genes in rat liver during regeneration and after carbon tetrachloride intoxication
88. Isolation of a multispecific organic anion and cardiac glycoside transporter from rat brain
89. Expression of the multidrug resistance-associated protein (MRP) gene in human cancers
90. Molecular mechanisms of organic cation transport in OCT2-expressing Xenopus oocytes
91. MRP3, a new ATP-binding cassette protein localized to the canalicular domain of the hepatocyte
92. A mutation in the human canalicular multispecific organic anion transporter gene causes the Dubin-Johnson syndrome
93. The multidrug resistance-associated protein (MRP) is over-expressed and functional in rat hepatoma cells
94. Reversal of MRP-mediated multidrug resistance in human lung cancer cells by the antiprogestatin drug RU486
95. Progesterone regulates the murine multidrug resistance mdr1b gene
96. Suppression of multi-drug resistance gene expression in the mouse liver by 1,4-bis[2,(3,5-dichloropyridyloxy)]benzene
97. Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs
98. Absence of the mdr1a P-glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A
99. Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins
100. Metabolic activation of 2-acetylaminofluorene is required for induction of multidrug resistance gene expression in rat liver cells
101. Multidrug resistance gene expression in rodents and rodent hepatocytes treated with mitoxantrone
102. Substrate specificity of the rat liver Na(+)-bile salt cotransporter in Xenopus laevis oocytes and in CHO cells
103. Interindividual variation in expression of P-glycoprotein in normal human liver and secondary hepatic neoplasms
104. Divergent regulation of the class II P-glycoprotein gene in primary cultures of hepatocytes versus H35 hepatoma by glucocorticoids
105. P-glycoprotein: A major determinant of rifampicin-inducible expression of cytochrome P4503A in mice and humans
106. MRP4: A previously unidentified factor in resistance to nucleoside-based antiviral drugs
107. Identification of multispecific organic anion transporter 2 expressed predominantly in the liver
108. Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease
109. Identification of a locus for progressive familial intrahepatic cholestasis PFIC2 on chromosome 2q24
110. A gene encoding a liver-specific ABC transporter is mutated in progressive familial intrahepatic cholestasis
111. Expression cloning and characterization of ROAT1. The basolateral organic anion transporter in rat kidney
112. Activation of distinct multidrug-resistance (P-glycoprotein) genes during rat liver regeneration and hepatocarcinogenesis
113. Expression of the multidrug-resistant gene in hepatocarcinogenesis and regenerating rat liver
114. p53-Dependent regulation of MDR1 gene expression causes selective resistance to chemotherapeutic agents
115. Sister of P-glycoprotein expression in different tissues
116. Endotoxin downregulates rat hepatic ntcp gene expression via decreased activity of critical transcription factors
117. Functional characteristics and membrane localization of rat multispecific organic cation transporters, OCT1 and OCT2, mediating tubular secretion of cationic drugs
118. Cortisol is transported by the multidrug resistance gene product P-glycoprotein
119. Up-regulation of the multidrug resistance genes, Mrp1 and Mdr1b, and down-regulation of the organic anion transporter, Mrp2, and the bile salt transporter, Spgp, in endotoxemic rat liver
120. Overlapping substrate specificities and tissue distribution of cytochrome P450 3A and P-glycoprotein: Implications for drug delivery and activity in cancer chemotherapy
121. Transcriptional suppression of multidrug resistance-associated protein (MRP) gene expression by wild-type p53
122. Regulation of bile salt export pump mRNA levels by dexamethasone and osmolarity in cultured rat hepatocytes
123. Induction of the multispecific organic anion transporter (cMoat/mrp2) gene and biliary glutathione secretion by the herbicide 2,4,5-trichlorophenoxyacetic acid in the mouse liver
124. Expression of multidrug resistance protein-3 (multispecific organic anion transporter-D) in human embryonic kidney 293 cells confers resistance to anticancer agents
125. Cloning and functional expression of a human liver organic cation transporter
126. Functional characterization of an organic cation transporter (hOCT1) in a transiently transfected human cell line (HeLa)
127. NF-kappaB-mediated induction of mdr1b expression by insulin in rat hepatoma cells
128. Wild-type p53-mediated induction of rat mdr1b expression by the anticancer drug daunorubicin